Register entry
Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 9
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
99 active NDC listings: 9 bulk ingredient. By marketing category: BULK INGREDIENT 9.
| Dosage form | NDCs |
|---|---|
| powder | 9 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| chunghwa chemical sysnthsis & biotech co.,ltd. | 9 |
Catalogue
Marketed products
9| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | BRIVARACETAM | powder | 52076-6268BULK INGREDIENT |
| - | Difelikefalin acetate | powder | 52076-6273BULK INGREDIENT |
| - | Eslicarbazepine acetate | powder | 52076-6269BULK INGREDIENT |
| - | Everolimus B02 | powder | 52076-6270BULK INGREDIENT |
| - | FAVIPIRAVIR | powder | 52076-6265BULK INGREDIENT |
| - | Lanreotide Acetate | powder | 52076-6272BULK INGREDIENT |
| - | OZANIMOD HYDROCHLORIDE | powder | 52076-6266BULK INGREDIENT |
| - | Setmelanotide Acetate | powder | 52076-6271BULK INGREDIENT |
| - | Tofacitinib citrate | powder | 52076-6267BULK INGREDIENT |
Compare
Other companies listing brivaracetam
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Micro Labs Limited5 sites · 141 NDC
- Pure and Cure Healthcare Private Limited3 sites · 14 NDC
- UCB, Inc.2 sites · 65 NDC
- Exelan Pharmaceuticals, Inc.0 sites · 181 NDC
Enquiry
Common questions
- Is Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd. FDA approved?
- Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd. holds no registered establishment of its own; 9 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd. make?
- 9 products are listed under Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.